Astal Laboratories Ltd Financials

Astal Laboratories Ltd Financial Statement

Astal Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Dec 2024	Sep 2024	Jun 2024
Revenue	14.51	13.16	13.18
Operating Expense	11.13	10.27	10.77
Net Profit	2.49	2	1.69
Net Profit Margin	17.16	15.20	12.82
Earning Per Share	2.53	2.04	1.72
EBIDTA	3.28	2.89	2.38
Effective Tax Rate	12.72	26.64	25.73

Particulars	Dec 2024
Revenue	14.51
Operating Expense	11.13
Net Profit	2.49
Net Profit Margin	17.16
Earning Per Share	2.53
EBIDTA	3.28
Effective Tax Rate	12.72

Astal Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	23.65	3.43	TBA
Operating Expenses Annual	22.53	3.57	0.21
Operating Profit Annual	1.13	0.04	-0.00
Interest Annual	0.01	TBA	TBA
Depreciation	0.03	0.01	0.01
Net Profit Annual	0.78	0.02	-0.02
Tax Annual	0.30	0.02	TBA

Particulars	Mar 2024
Total Revenue Annual	23.65
Operating Expenses Annual	22.53
Operating Profit Annual	1.13
Interest Annual	0.01
Depreciation	0.03
Net Profit Annual	0.78
Tax Annual	0.30

Astal Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.08	0.02	0.03
Cash Flow from Operations	-5.59	-1.44	-0.25
Cash Flow from Investing	-6.11	1.50	0.24
Cash Flow from Financing	17.69	TBA	TBA
Cash Flow at the End	6.08	0.08	0.02

Particulars	Mar 2024
Cash Flow at the Beginning	0.08
Cash Flow from Operations	-5.59
Cash Flow from Investing	-6.11
Cash Flow from Financing	17.69
Cash Flow at the End	6.08

Astal Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	4.78	1.17	TBA
PBIT Margin (%)	4.65	0.87	TBA
PBT Margin (%)	-456.24	0.87	TBA
Net PROFIT Margin (%)	3.30	0.58	TBA
Return On Networth / Equity (%)	5.47	0.39	-0.39
Return On Networth /Employed (%)	7.56	0.77	-0.19
Return On Assets (%)	5.41	0.38	TBA
Total Debt / Equity (X)	0.01	TBA	TBA
Asset Turnover Ratio (%)	1.64	0.66	TBA

Particulars	Mar 2024
PBDIT Margin (%)	4.78
PBIT Margin (%)	4.65
PBT Margin (%)	-456.24
Net PROFIT Margin (%)	3.30
Return On Networth / Equity (%)	5.47
Return On Networth /Employed (%)	7.56
Return On Assets (%)	5.41
Total Debt / Equity (X)	0.01
Asset Turnover Ratio (%)	1.64

Astal Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	0.69	0.01	0.01
Total Current Assets Annual	26.73	6.11	0.10
Non Current Assets Annual	9.89	3.79	5.13
Total Shareholders Funds Annual	23.34	5.18	5.16
Total Assets Annual	36.61	9.91	5.23

Particulars	Mar 2024
Fixed Assets Annual	0.69
Total Current Assets Annual	26.73
Non Current Assets Annual	9.89
Total Shareholders Funds Annual	23.34
Total Assets Annual	36.61

Astal Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Astal Laboratories Ltd Financials

As of Feb 22, 2025, Astal Laboratories Ltd has a market capitalization of 40.19 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Astal Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.01.

In FY 2024 , Astal Laboratories Ltd recorded a total revenue of approximately 23.65 Cr marking a significant milestone in the company's financial performance.

Astal Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.9% and Infinity% annually, respectively..

Astal Laboratories Ltd's current PE ratio is 51.53.

Astal Laboratories Ltd's ROCE averaged 1.6% from the FY ending March 2022 to 2024, with a median of 0.6%. It peaked at 4.6% in March 2024, reflecting strong capital efficiency over the period..

Astal Laboratories Ltd's latest EBIT is Rs. 1.10 Cr, surpassing the average EBIT of Rs. 0.37 Cr over the 5 years..